Results 151 to 160 of about 86,630 (338)

Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents

, 2020
Animeshchandra G. M. Haldar, Santosh S. Chhajed, Akanksha Ravindra Ugale, Sanjay J. Kshirsagar, Kanhaiya M. Dadure, Debarshi Kar Mahapatra   +5 more
openalex   +1 more source

Barnes Hospital Bulletin [PDF]

, 1977
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1143/thumbnail ...

core   +1 more source

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin, Ming‐Lun Yeh, Po‐Cheng Liang, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang   +8 more
wiley   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao, Jing Zhou, Jing Wang, Si‐Nan Zhao, Zhan‐Sheng Zhao, Qian Wang, Ya‐Nan Xie, Wei Jiao   +7 more
wiley   +1 more source

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents. [PDF]

Molecules, 2022
Xu B, Li Z, Zeng T, Zhan J, Wang S, Ho CT, Li S.   +6 more
europepmc   +1 more source

Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease [PDF]

, 2012
Rosa Maria Rahmi Garcia, Augusto Hiroshi Uchida, Paulo Cury Rezende, Eduardo Gomes Lima, Cibele Larrosa Garzillo, Desidério Favarato, Célia Maria Cássaro Strunz, Myrthes Emy Takiuti, Priscyla Girardi, Whady Hueb, Roberto Kalil Filho, José Antônio Franchini Ramires   +11 more
openalex   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

Correction: Khayat et al. Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 2022, 10, 2455 [PDF]

Maan T. Khayat, Tarek S. Ibrahim, Khaled M. Darwish, Ahdab N. Khayyat, Majed Alharbi, El‐Sayed Khafagy, Mohamed A. M. Ali, Wael A. H. Hegazy, Hisham A. Abbas   +8 more
openalex   +1 more source

Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals. Methods A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381).
Inês Rego de Figueiredo, Filipa Sofia Simas, Angela Ghiletchi, João Oliveira Torres, José Silva‐Nunes   +4 more
wiley   +1 more source

Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review

Frontiers in Pharmacology
The colossal global burden of diabetes management is compounded by the serious complication of hypoglycemia. Protective physiologic hormonal and neurogenic counterregulatory responses to hypoglycemia are essential to preserve glucose homeostasis and ...
Hiba Z. Hashmi, Ameer Khowaja, Amir Moheet   +2 more
doaj   +1 more source